Cary Street Partners’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Buy
118,224
+9,950
+9% +$241K 0.06% 293
2026
Q1
$2.62M Buy
108,274
+1,561
+1% +$37.9K 0.07% 283
2025
Q4
$2.59M Buy
106,713
+53,430
+100% +$1.3M 0.06% 294
2025
Q3
$1.3M Buy
53,283
+5,137
+11% +$125K 0.03% 382
2025
Q2
$1.17M Sell
48,146
-1,018
-2% -$24.6K 0.03% 396
2025
Q1
$1.19M Buy
49,164
+1,105
+2% +$26.6K 0.04% 357
2024
Q4
$1.15M Buy
+48,059
New +$1.16M 0.04% 353

Other funds holding IBDS

Cary Street Partners's IBDS Position: Q2 2026 in Review

Cary Street Partners increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 9.2% in Q2 2026, buying an estimated $241K and bringing the position to 118,224 shares worth $2.86M. The position accounts for 0.06% of the portfolio, ranked #293.

Cary Street Partners first reported a position in IBDS in Q4 2024 and has held it in 7 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Cary Street Partners held 118,224 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $2.86M as of Q2 2026.
  • Cary Street Partners bought 9,950 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $241K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.06% of Cary Street Partners's portfolio in Q2 2026, its #293 holding.
  • Cary Street Partners first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.